Viewing a single comment thread. View all comments

OneDayCloserToDeath t1_jdwtzoj wrote

And how do you stop the virus from infecting healthy cells and causing more harm than good?

12

Toranagas1 t1_jebqx8n wrote

The technology they is referring to uses whole genome sequencing to identify InDel mutations in tumor cells then uses Cas9/gRNA specifc for those InDel sequences to induce double stranded DNA breaks, resulting in cell death. Since those sequences don't in theory exist elsewhere in the patient, it may be safe. Looks like a lot of different gRNAs are needed though for good efficacy.

They use lentivirus and AAVs to deliver them in vivo.

The in vivo efficacy data is...fine. The big thing here is the personalized medicine aspect.

PMID: 35217600

1

JackD4wkins t1_jdxda7b wrote

Because you coded the the virus enzyme to specifically target cancer DNA and not healthy DNA. Even if the virus infects a healthy cell, it will have no effect

−2

OneDayCloserToDeath t1_jdxhmrz wrote

Is this done? Do you have any information on it working?

3

JackD4wkins t1_jdxjblw wrote

They're working on it in South Korea. Its called the CINDELA program. Not sure what the status is

0

ecnecn t1_jdzehcr wrote

>CINDELA program

You mean Cancer-Specific InDel Attacker (Cindela) ? I didnt know they use reprogrammed viruses...

1